loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 76290 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Hikma Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 HIKMA (1)

    filter

    01 CREAM;TOPICAL (1)

    filter

    01 RX (1)

    filter

    01 LIDOCAINE AND PRILOCAINE (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag United Kingdom
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    LIDOCAINE; PRILOCAINE

    PDF Supplier PDF
    URL Supplier Web Content
    CREAM; TOPICAL
    2.5%;2.5%
    2003-09-25
    76290
    LIDOCAINE AND PRIL...
    RX
    No
    AB
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 76290

    Looking for FDA Orange Book APPLICATION 76290 1

    19

    Hikma Pharmaceuticals, based in United Kingdom, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is LIDOCAINE; PRILOCAINE, with a corresponding application number 76290.

    Regulatory Information RX

    With a dosage strength 2.5%;2.5%

    Dosage Form Route CREAM; TOPICAL

    Reference Listed Drug No

    Approved since 2003-09-25

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY